Jump to content

Asuragen

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Woodidoo (talk | contribs) at 11:38, 26 March 2020 (hiring of new senior vice president). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Asuragen is a biotechnology company based in Austin, Texas involved in diagnostics and therapeutics.

Asuragen
IndustryBiotechnology
FoundedMarch 2006 (2006-03)
Headquarters
Austin, Texas
,
United States
DivisionsDiagnostics, Translational Diagnostics
Websitehttp://www.asuragen.com/

History

In 1989 Dr. Matt Winkler left his position as an Associate Professor of Zoology at the University of Texas and formed a molecular biology reagent company called Ambion. Winkler then formed Asuragen from Ambion's Molecular Diagnostics and Pharmacogenomic Service Divisions following the March 2006 sale of the Research Products Division of Ambion Inc. to the Applied Biosystems Group (currently Life Technologies).[1] In December 2007, the microRNA therapeutics activities were moved into a new entity called Mirna Therapeutics.[2]

In October 2018, Asuragen announced the hiring of Tom Copa as senior vice president for commercial operations.[3][4]

Products and Services

Asuragen's offerings include molecular diagnostic products providing identification of genetic abnormalities associated with oncology and genetic diseases. The company also provides RNA-related services and PCR kits designed for protein detection.[5] The company received $49 million in funding in 2006.[6]

In 2018, Asuragen was named one of the primary producers of PCR reagents by Apex Market Reports.[7]

References

  1. ^ Rockwell, Lily (December 10, 2007), "Asuragen gets push forward", Austin American Statesman, pp. D2, D4
  2. ^ Harrington, Kate (January 18–24, 2008), "Asuragen launches new microRNA firm", Austin Business Journal, pp. 3, 7
  3. ^ "Asuragen Announces New Commercial Leadership Appointment". www.bloomberg.com. Retrieved 2020-03-26.{{cite web}}: CS1 maint: url-status (link)
  4. ^ "Asuragen Announces New Commercial Leadership Appointment". BioSpace. Retrieved 2020-03-26.
  5. ^ "New Products Posted to GenomeWeb: PerkinElmer, Phase Genomics, Pacific Biosciences, Asuragen, More". Genome Web. 1 June 2018. Retrieved 19 June 2018.
  6. ^ Seldon, Johathan (May 28, 2006), "49M in venture funds bring Asuragen to life", Austin Business Journal, pp. D2, D4
  7. ^ "PCR Reagent Market Research Report 2018". Apex Market Reports. 2018. Retrieved 19 June 2018.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Asuragen&oldid=947450654"